These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 29880781

  • 1. Inhibition and Inactivation of Uropathogenic Escherichia coli Biofilms on Urinary Catheters by Sodium Selenite.
    Narayanan A, Nair MS, Muyyarikkandy MS, Amalaradjou MA.
    Int J Mol Sci; 2018 Jun 07; 19(6):. PubMed ID: 29880781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibiofilm effect of trans-cinnamaldehyde on uropathogenic Escherichia coli.
    Amalaradjou MA, Narayanan A, Baskaran SA, Venkitanarayanan K.
    J Urol; 2010 Jul 07; 184(1):358-63. PubMed ID: 20488489
    [Abstract] [Full Text] [Related]

  • 4. Carvacrol-rich oregano oil and thymol-rich thyme red oil inhibit biofilm formation and the virulence of uropathogenic Escherichia coli.
    Lee JH, Kim YG, Lee J.
    J Appl Microbiol; 2017 Dec 07; 123(6):1420-1428. PubMed ID: 28980415
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F, Yang H, Bi D, Khaledi A, Qiao M.
    Microb Pathog; 2020 Jul 07; 144():104196. PubMed ID: 32283258
    [Abstract] [Full Text] [Related]

  • 9. Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.
    Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, Schmitz JE, Hadjifrangiskou M.
    Int J Mol Sci; 2017 Sep 30; 18(10):. PubMed ID: 28973965
    [Abstract] [Full Text] [Related]

  • 10. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS, Cusumano CK, Kline KA, Dodson KW, Han Z, Janetka JW, Henderson JP, Caparon MG, Hultgren SJ.
    Antimicrob Agents Chemother; 2012 Sep 30; 56(9):4738-45. PubMed ID: 22733070
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive phenotypic and genotypic characterization and comparison of virulence, biofilm, and antimicrobial resistance in urinary Escherichia coli isolated from canines.
    Gilbertie JM, Levent G, Norman KN, Vinasco J, Scott HM, Jacob ME.
    Vet Microbiol; 2020 Oct 30; 249():108822. PubMed ID: 32937249
    [Abstract] [Full Text] [Related]

  • 12. Suppressing the phenotypic virulence factors of Uropathogenic Escherichia coli using marine polysaccharide.
    Rubini D, Varthan PV, Jayasankari S, Vedahari BN, Nithyanand P.
    Microb Pathog; 2020 Apr 30; 141():103973. PubMed ID: 31927002
    [Abstract] [Full Text] [Related]

  • 13. Biosynthesis of silver nanoparticles by Fusarium scirpi and its potential as antimicrobial agent against uropathogenic Escherichia coli biofilms.
    Rodríguez-Serrano C, Guzmán-Moreno J, Ángeles-Chávez C, Rodríguez-González V, Ortega-Sigala JJ, Ramírez-Santoyo RM, Vidales-Rodríguez LE.
    PLoS One; 2020 Apr 30; 15(3):e0230275. PubMed ID: 32163495
    [Abstract] [Full Text] [Related]

  • 14. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
    Shen XF, Ren LB, Teng Y, Zheng S, Yang XL, Guo XJ, Wang XY, Sha KH, Li N, Xu GY, Tian HW, Wang XY, Liu XK, Li J, Huang N.
    Food Chem Toxicol; 2014 Oct 30; 72():204-11. PubMed ID: 25051393
    [Abstract] [Full Text] [Related]

  • 15. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
    González MJ, Da Cunda P, Notejane M, Zunino P, Scavone P, Robino L.
    Pathog Dis; 2019 Apr 01; 77(3):. PubMed ID: 31062019
    [Abstract] [Full Text] [Related]

  • 16. Outcome of acute urinary tract infections caused by uropathogenic Escherichia coli with phenotypically demonstrable virulence factors.
    Pullanhi U, Khan S, Vinod V, Mohan K, Kumar A.
    Ann Afr Med; 2019 Apr 01; 18(3):138-142. PubMed ID: 31417014
    [Abstract] [Full Text] [Related]

  • 17. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
    Javed S, Mirani ZA, Pirzada ZA.
    Libyan J Med; 2021 Dec 01; 16(1):1845444. PubMed ID: 33170767
    [Abstract] [Full Text] [Related]

  • 18. Characterization and zoonotic potential of uropathogenic Escherichia coli isolated from dogs.
    Nam EH, Ko S, Chae JS, Hwang CY.
    J Microbiol Biotechnol; 2013 Mar 01; 23(3):422-9. PubMed ID: 23462017
    [Abstract] [Full Text] [Related]

  • 19. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
    Mittal S, Sharma M, Chaudhary U.
    Pathog Glob Health; 2015 Feb 01; 109(1):26-9. PubMed ID: 25605466
    [Abstract] [Full Text] [Related]

  • 20. Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli.
    Miryala S, Makala H, Yadavali SP, Venkatasubramanian U, Subbaiah N, Srinandan CS.
    Microb Pathog; 2020 Jan 01; 138():103772. PubMed ID: 31589910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.